Daewon Pharmaceutical Co., Ltd. (KRX:003220)
10,190
-510 (-4.77%)
Mar 9, 2026, 3:30 PM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 218.41 billion as of March 9, 2026. Its market cap has decreased by -28.69% in one year.
Market Cap
218.41B
Enterprise Value
371.29B
Revenue
590.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,190.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 218.41B, an increase of 1,109.34%. That is a compound annual growth rate of 10.47%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chong Kun Dang Holdings | 233.27B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Samil Pharmaceutical Co.,Ltd | 223.34B |
| Samjin Pharmaceuticals | 222.85B |
| Suheung | 240.73B |
| HLB Pharmaceutical | 212.04B |
| Jeil Pharmaceutical Co.,Ltd | 210.56B |
| JW Lifescience | 200.22B |